Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer

Myung Ju Ahn

doi:10.21037/jtd.2018.03.55

Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer

Myung Ju Ahn

Sungkyunkwan University

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Pages (from-to)	1205-1206
Number of pages	2
Journal	Journal of Thoracic Disease
Volume	10
Issue number	3
DOIs	https://doi.org/10.21037/jtd.2018.03.55
State	Published - 1 Mar 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/jtd.2018.03.55

Cite this

@article{5600f076d88c40efb9cd3ab7f9af7eca,

title = "Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer",

author = "Ahn, \{Myung Ju\}",

year = "2018",

month = mar,

day = "1",

doi = "10.21037/jtd.2018.03.55",

language = "English",

volume = "10",

pages = "1205--1206",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "AME Publishing Company",

number = "3",

}

TY - JOUR

T1 - Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer

AU - Ahn, Myung Ju

PY - 2018/3/1

Y1 - 2018/3/1

UR - https://www.scopus.com/pages/publications/85045256214

U2 - 10.21037/jtd.2018.03.55

DO - 10.21037/jtd.2018.03.55

M3 - Editorial

AN - SCOPUS:85045256214

SN - 2072-1439

VL - 10

SP - 1205

EP - 1206

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 3

ER -

Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer

UN SDGs

Access to Document

Other files and links

Cite this